Jul 26 WATCH: Patients affected by rising drug prices testified before House committee By Laura Santhanam The hearing on Capitol Hill comes at a time when the Trump administration has made a push to reduce drug prices and the cost of healthcare overall. Continue reading
Jul 23 Senators unveil compromise to reduce drug costs for seniors By Ricardo Alonso-Zaldivar, Associated Press The bill would for the first time limit drug copays for people with Medicare's "Part D" prescription plan, by capping patients' out-of-pocket costs at $3,100 a year starting in 2022. Continue reading
Jul 09 Judge strikes down Trump rule requiring prescription ads to list prices By Ricardo Alonso-Zaldivar, Associated Press Drugmakers had argued that requiring them to disclose list prices amounted to coercion that would violate their free speech rights under the Constitution. Continue reading
May 23 Republicans and Democrats team up to address surprise medical bills By Ricardo Alonso-Zaldivar, Associated Press Senior lawmakers of both parties proposed legislation to tackle surprise medical bills, prescription drug costs and uneven vaccination rates. Continue reading
May 09 WATCH: Trump advocates push against ‘surprise medical bills’ By Kevin Freking, Ricardo Alonso-Zaldivar, Associated Press President Donald Trump on Thursday called for an end to the astonishingly high charges insured patients can face when a member of a medical team that treats them is not in their insurer's network. Continue reading
Apr 11 Column: Drug companies try shifting blame for high prices under lawmakers’ scrutiny By Philip Moeller Rising insulin prices are once again shining an uncomfortable spotlight on drug-company CEOs, who have been dutifully taking a public pounding before congressional committees. Continue reading
Feb 26 Watch 5:56 Lawmakers grill pharmaceutical executives over drug prices, but CEOs avoid big pledges Health care costs are a major concern for Americans, who spend more on prescription drugs than residents of any other country. On Tuesday, executives from seven of the biggest pharmaceutical companies appeared before a Senate committee to explain their rising… Continue watching
Feb 01 Watch 9:24 Sec. Azar on how new proposal ‘brings transparency’ to drug pricing A new rule bans pharmaceutical companies from providing rebates to middlemen and insurers in exchange for choosing their drugs. Health and Human Services Secretary Alex Azar also called on Congress to pass a new prescription drug discount plan that would… Continue watching
Sep 25 Watch 6:41 Why the Trump administration isn’t making much headway in lowering drug prices President Trump made reducing drug prices a focus of his campaign, and his administration has taken some steps to do so. But a recent analysis of more than 26,000 U.S. brand name prescription drugs found 96 price hikes for every… Continue watching
May 14 Watch 9:46 HHS Secretary Azar: Trump’s drug prices proposal is better than campaign pledge President Trump laid out his long-awaited plan for tackling drug prices on Friday. Health and Human Services Secretary Alex Azar joins Judy Woodruff to fill in the details about the plan, including how it will affect prices under Medicare, why… Continue watching